Analysts Viewpoint Cg Oncology Inc (CGON) rating initates by Piper Sandler Cg Oncology Inc’s recently made public that its Director Mulay James unloaded Company’s shares for reported $0.75 million on Sep
Analysts Viewpoint CGON stock rated an Overweight by Piper Sandler Cg Oncology Inc’s recent filing unveils that its Director Mulay James unloaded Company’s shares for reported $0.75 million on Sep
Insiders Updates Examining the Potential Price Growth of Cg Oncology Inc (CGON) Cg Oncology Inc’s recent filing unveils that its Director LEONARD E POST acquired Company’s shares for reported $0.1 million on
Stock Earnings Positive sentiment towards CGON reflected in decline in short interest Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cg Oncology